Alireza Nourazarian

Dr. Alireza Nourazarian

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
ANAlireza Nourazarian
Alireza Nourazarian
PKParisa Kangari
Parisa Kangari
ASArash Salmaninejad
Arash Salmaninejad
Roles of Oxidative Stress in the Development and Progression of Breast Cancer Oxidative stress;breast cancer;free radicals;reactive oxygen species (ROS); Oxidative stress is caused by an imbalance in the redox status of the body. In such a state, increase of free radicals in the body can lead to tissue damage. One of the most important species of free radicals is reactive oxygen species (ROS) produced by various metabolic pathways, including aerobic metabolism in the mitochondrial respiratory chain. It plays a critical role in the initiation and progression of various types of cancers. ROS affects different signaling pathways, including growth factors and mitogenic pathways, and controls many cellular processes, including cell proliferation, and thus stimulates the uncontrolled growth of cells which encourages the development of tumors and begins the process of carcinogenesis. Increased oxidative stress caused by reactive species can reduce the body's antioxidant defense against angiogenesis and metastasis in cancer cells. These processes are main factors in the development of cancer. Bimolecular reactions cause free radicals in which create such compounds as malondialdehyde (MDA) and hydroxyguanosine. These substances can be used as indicators of cancer. In this review, free radicals as oxidizing agents, antioxidants as the immune system, and the role of oxidative stress in cancer, particularly breast cancer, have been investigated in the hope that better identification of the factors involved in the occurrence and spread of cancer will improve the identification of treatment goals.

12 November 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CACigir Biray Avci
Cigir Biray Avci
BBBakiye Goker Bagca
Bakiye Goker Bagca
MNMasoud Nikanfar
Masoud Nikanfar
LTLeila Sabour Takanlou
Leila Sabour Takanlou
MTMaryam Sabour Takanlou
Maryam Sabour Takanlou
ANAlireza Nourazarian
Alireza Nourazarian
The tumor microenvironment (TME) plays a crucial role in cancer development and metastasis. This review summarizes the current research on how the TME promotes metastasis through molecular pathways, focusing on key components, such as cancer-associated fibroblasts, immune cells, endothelial cells, cytokines, and the extracellular matrix. Significant findings have highlighted that alterations in cellular communication within the TME enable tumor cells to evade immune surveillance, survive, and invade other tissues. This review highlights the roles of TGF-β and VEGF signaling in promoting angiogenesis and extracellular matrix remodeling, which facilitate metastasis. Additionally, we explored how metabolic reprogramming of tumor and stromal cells, influenced by nutrient availability in the TME, drives cancer progression. This study also evaluated the therapeutic strategies targeting these interactions to disrupt metastasis. By providing a multidisciplinary perspective, this study suggests that understanding the molecular basis of the TME can lead to more effective cancer therapies and identify potential avenues for future research. Future research on the TME should prioritize unraveling the molecular and cellular interactions within this complex environment, which could lead to novel therapeutic strategies and personalized cancer treatments. Moreover, advancements in technologies such as single-cell analysis, spatial transcriptomics, and epigenetic profiling offer promising avenues for identifying new therapeutic targets and improving the efficacy of immunotherapies, particularly in the context of metastasis.

11 May 2017 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
Jafar RezaieJafar Rezaie
Jafar Rezaie
SASaeed Ajezi
Saeed Ajezi
ÇAÇığır Biray Avci
Çığır Biray Avci
MKMohammad Karimipour
Mohammad Karimipour
MGMohammad Hossein Geranmayeh
Mohammad Hossein Geranmayeh
RRReza Rahbarghazi
Reza Rahbarghazi

2 November 2023 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
HBHaleh Barmaki
Haleh Barmaki
ANAlireza Nourazarian
Alireza Nourazarian
FKFatemeh Khaki-Khatibi
Fatemeh Khaki-Khatibi
Alzheimer's disease (AD) is characterized by the accumulation of misfolded amyloid-beta and tau proteins. Autophagy acts as a proteostasis process to remove protein clumps, although it progressively weakens with aging and AD, thus facilitating the accumulation of toxic proteins and causing neurodegeneration. This review examines the impact of impaired autophagy on the progression of AD disease pathology. Under normal circumstances, autophagy removes abnormal proteins and damaged organelles, but any dysfunction in this process can lead to the exacerbation of amyloid and tau pathology, particularly in AD. There is increasing attention to therapeutic tactics to revitalize autophagy, including reduced caloric intake, autophagy-stimulating drugs, and genetic therapy. However, the translation of these strategies into clinical practice faces several hurdles. In summary, this review integrates the understanding of the intricate role of autophagy dysfunction in Alzheimer's disease progression and reinforces the promising prospects of autophagy as a beneficial target for treatments to modify the course of Alzheimer's disease.

5 August 2016 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MMMaryam Majidinia
Maryam Majidinia
AMAynaz Mihanfar
Aynaz Mihanfar
RRReza Rahbarghazi
Reza Rahbarghazi
ANAlireza Nourazarian
Alireza Nourazarian
BBBakiyeGoker Bagca
BakiyeGoker Bagca
ÇAÇığır Biray Avci
Çığır Biray Avci

4 February 2015 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
YBYaser Khaje Bishak
Yaser Khaje Bishak
LPLaleh Payahoo
Laleh Payahoo
AOAlireza Osatdrahimi
Alireza Osatdrahimi
ANAlireza Nourazarian
Alireza Nourazarian
Mechanisms of Cadmium Carcinogenicity in the Gastrointestinal Tract Cadmium;gastric cancer;DNA damage repair;antioxidant enzymes; Cancer, a serious public health problem in worldwide, results from an excessive and uncontrolled proliferation of the body cells without obvious physiological demands of organs. The gastrointestinal tract, including the esophagus, stomach and intestine, is a unique organ system. It has the highest cancer incidence and cancer-related mortality in the body and is influenceed by both genetic and environmental factors. Among the various chemical elements recognized in the nature, some of them including zinc, iron, cobalt, and copper have essential roles in the various biochemical and physiological processes, but only at low levels and others such as cadmium, lead, mercury, arsenic, and nickel are considered as threats for human health especially with chronic exposure at high levels. Cadmium, an environment contaminant, cannot be destroyed in nature. Through impairment of vitamin D metabolism in the kidney it causes nephrotoxicity and subsequently bone metabolism impairment and fragility. The major mechanisms involved in cadmium carcinogenesis could be related to the suppression of gene expression, inhibition of DNA damage repair, inhibition of apoptosis, and induction of oxidative stress. In addition, cadmium may act through aberrant DNA methylation. Cadmium affects multiple cellular processes, including signal transduction pathways, cell proliferation, differentiation, and apoptosis. Down-regulation of methyltransferases enzymes and reduction of DNA methylation have been stated as epigenetic effects of cadmium. Furthermore, increasing intracellular free calcium ion levels induces neuronal apoptosis in addition to other deleterious influence on the stability of the genome.